Kashiv BioSciences Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
600
- Latest Deal Type
-
M&A
- Financing Rounds
-
5
- Investments
-
1
Kashiv BioSciences General Information
Description
Provider of pharmaceutical research and drug delivery services designed to create improved versions of known medicines with clinical differentiation. The company develops drug delivery platforms, healthcare technologies, and life-cycle management products, enabling patients and physicians to access enhanced treatments for cancer and other unmet medical needs.
Contact Information
Website
www.kashivbiosciences.com(Operating Subsidiary)
Corporate Office
- 20 New England Avenue
- Piscataway, NJ 08854
- United States
Corporate Office
- 20 New England Avenue
- Piscataway, NJ 08854
- United States
Kashiv BioSciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kashiv BioSciences Comparisons
Industry
Financing
Details
Kashiv BioSciences Competitors (3)
One of Kashiv BioSciences’s 3 competitors is Nemera, a Private Equity-Backed company based in Lyon, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nemera | Private Equity-Backed | Lyon, France | ||||
| Altus Formulation (Other Pharmaceuticals and Biotechnology) | Corporation | Atlanta, GA | ||||
| Athena Pharmaceutiques | Private Equity-Backed | Louveciennes, France |
Kashiv BioSciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kashiv BioSciences Patents
Kashiv BioSciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026146462-A1 | A process for the preparation of stable pegylated protein mixture suitable for analytical characterization | Pending | 06-Jan-2025 | ||
| WO-2026126079-A1 | A stable pharmaceutical composition of fusion protein | Pending | 11-Dec-2024 | ||
| WO-2026126081-A1 | A stable pharmaceutical composition of fusion protein | Pending | 11-Dec-2024 | ||
| WO-2026093842-A1 | A process for producing fc-fusion protein in mammalian cell culture | Pending | 30-Oct-2024 | ||
| WO-2026062615-A2 | A method for the production of recombinant fusion protein | Pending | 23-Sep-2024 | C12N15/63 |
Kashiv BioSciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kashiv BioSciences Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kashiv BioSciences Acquisitions (1)
Kashiv BioSciences’s most recent deal was a Merger/Acquisition with Adello Biologics. The deal was made on 03-Jan-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Adello Biologics | 03-Jan-2019 | Merger/Acquisition | Drug Discovery |
Kashiv BioSciences FAQs
-
When was Kashiv BioSciences founded?
Kashiv BioSciences was founded in 2010.
-
Where is Kashiv BioSciences headquartered?
Kashiv BioSciences is headquartered in Piscataway, NJ.
-
What is the size of Kashiv BioSciences?
Kashiv BioSciences has 600 total employees.
-
What industry is Kashiv BioSciences in?
Kashiv BioSciences’s primary industry is Drug Delivery.
-
Is Kashiv BioSciences a private or public company?
Kashiv BioSciences is a Private company.
-
What is the current valuation of Kashiv BioSciences?
The current valuation of Kashiv BioSciences is .
-
What is Kashiv BioSciences’s current revenue?
The current revenue for Kashiv BioSciences is .
-
How much funding has Kashiv BioSciences raised over time?
Kashiv BioSciences has raised $222M.
-
Who are Kashiv BioSciences’s investors?
Avtar Investments, New Jersey Division of Investment, and Tarsadia Investments have invested in Kashiv BioSciences.
-
Who are Kashiv BioSciences’s competitors?
Nemera, Altus Formulation (Other Pharmaceuticals and Biotechnology), and Athena Pharmaceutiques are competitors of Kashiv BioSciences.
-
When was Kashiv BioSciences acquired?
Kashiv BioSciences was acquired on 10-Aug-2026.
-
Who acquired Kashiv BioSciences?
Kashiv BioSciences was acquired by Amneal Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
